Dropcova et al., 1992 - Google Patents

The influence of some organic compounds used for the preparation of eye drops on the hydration of the cornea a histochemical study

Dropcova et al., 1992

View PDF

Document ID: 3269511983260016083
Author: Dropcova S; Cejkova J; Lojda Z
Publication year: 1992
Publication venue: Acta histochemica et cytochemica

External Links

Cited by

Snippet

RESULTS Histochemical examination Single dropping of cellulose acetate phthalate, propylene glycol, and polyvinylpyrrolidone did not cause any change of corneal hydration. After repeated dropping of these drugs a decreased activity of Na+-K+-dependent ATP-ase …

Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

210000004087 Cornea 0 title abstract description 22

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

Similar Documents

Publication	Publication Date	Title
US10632155B2 (en)	2020-04-28	Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
RU2184448C2 (en)	2002-07-10	Solution to store corneal tissues including hyaluronic acid
KR100353377B1 (en)	2002-12-26	Drug solution based on diclofenac and tobramycin
Graue et al.	1980	The protective effect of Na-hyaluronate to corneal endothelium
Gicquel et al.	2007	Amniotic membrane transplantation in severe bacterial keratitis
Hagenah et al.	1995	Incidence of bacterial and fungal contamination of donor corneas preserved by organ culture
US5728405A (en)	1998-03-17	Method for preventing keratocyte loss
Yau et al.	1986	A medium-term corneal preserving medium (K-Sol)
Dropcova et al.	1992	The influence of some organic compounds used for the preparation of eye drops on the hydration of the cornea a histochemical study
Nagai et al.	2013	Decrease in corneal damage due to benzalkonium chloride by the addition of sericin into timolol maleate eye drops
CN111955455B (en)	2021-11-30	Preservation solution for maintaining cornea activity
JPH0748262A (en)	1995-02-21	Extraocular application composition
Zhu et al.	2020	Corneal graft melting: a systematic review
Lindstrom et al.	1987	Corneal preservation at 4 degrees C with chondroitin sulfate containing medium.
Katz et al.	1989	Corneal thickness in nephropathic cystinosis.
Thoft et al.	1976	Corneal epithelial changes during midterm storage.
Čeiková et al.	1988	Disturbances in the rabbit cornea after short-term and long-term wear of hydrogel contact lenses: usefulness of histochemical methods
Karahan et al.	2021	Analysis of patients undergoing amniotic membrane transplantation at a tertiary referral hospital
Coles	1975	Effects of antibiotics on the in vitro rabbit corneal endothelium.
Čejkovä et al.	1998	Reactive oxygen species (ROS) generated by xanthine oxidase in the corneal epithelium and thelr potential participation in the damage of the corneal epithelium after prolonged use of contact lenses in rabbits
Biros et al.	2002	Regional and zonal variations in the sulfation patterns of chondroitin sulfate in normal equine corneal stroma
Bahn et al.	1981	Endothelial physiology and intraocular lens implantation
Sugar et al.	1986	Treatment of experimental Pseudomonas corneal ulcers with enoxacin, a quinolone antibiotic
Chayakul et al.	1982	The enzymatic activities in the alkali-burnt rabbit cornea
Wiederholt et al.	1979	Effect of intraocular irrigating solutions on intracellular membrane potentials and swelling rate of isolated human and rabbit cornea.